Inventor · disambiguated record
Mikkel Wandahl Pedersen
Also filed as: PEDERSEN MIKKEL · PEDERSEN MIKKEL W · PEDERSEN MIKKEL WANDAHL
17 granted patents·8 pending applications·153 citations·filing 2008–2025
93Inventor score
Files withSYMPHOGEN AS14PEDERSEN MIKKEL WANDAHL4SERVIER LAB4CHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD2PEDERSEN MIKKEL W1
Top patents by PatentIndex Score
25 records- 0193US11034765B2Anti-PD-1 antibodies and compositionsSYMPHOGEN AS·Filed 2016·Granted Jun 15, 2021·17 cites·20 claims
- 0293US8609095B2Anti-HER2 antibodies and compositionsPEDERSEN MIKKEL WANDAHL·Filed 2011·Granted Dec 17, 2013·22 cites·13 claims
- 0393US7887805B2Recombinant anti-epidermal growth factor receptor antibody compositionsSYMPHOGEN AS·Filed 2008·Granted Feb 15, 2011·56 cites·53 claims
- 0491US10058610B2Methods for treating cancer by administering humanized pan-HER antibody compositionsSYMPHOGEN AS·Filed 2016·Granted Aug 28, 2018·9 cites·20 claims
- 0587US8414896B2Recombinant anti-epidermal growth factor receptor antibody compositionsPEDERSEN MIKKEL WANDAHL·Filed 2010·Granted Apr 9, 2013·17 cites·32 claims
- 0686US11390676B2Anti-LAG-3 antibodies and compositionsSYMPHOGEN AS·Filed 2017·Granted Jul 19, 2022·3 cites·15 claims
- 0785US11390674B2Anti-TIM-3 antibodies and compositionsSYMPHOGEN AS·Filed 2017·Granted Jul 19, 2022·4 cites·23 claims
- 0883US9217039B2Anti-HER3 antibodies and compositionsPEDERSEN MIKKEL WANDAHL·Filed 2011·Granted Dec 22, 2015·10 cites·14 claims
- 0979US9155802B2Pan-HER antibody compositionPEDERSEN MIKKEL W·Filed 2011·Granted Oct 13, 2015·4 cites·18 claims
- 1077US9527913B2Humanized pan-HER antibody compositionsSYMPHOGEN AS·Filed 2013·Granted Dec 27, 2016·4 cites·8 claims
- 1176US10221246B2Pan-HER antibody compositionSYMPHOGEN AS·Filed 2016·Granted Mar 5, 2019·2 cites·8 claims
- 1276US8663640B2Methods using recombinant anti-epidermal growth factor receptor antibody compositionsPEDERSEN MIKKEL WANDAHL·Filed 2009·Granted Mar 4, 2014·4 cites·59 claims
- 1375US2024052032A1Anti-lag-3 antibodies and compositionsCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2023·Application pending·0 cites
- 1473US11834503B2Anti-lag-3 antibodies and compositionsCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2022·Granted Dec 5, 2023·0 cites·20 claims
- 1573US2024270848A1Combination therapies targeting pd-1, tim-3, and lag-3SERVIER LAB·Filed 2024·Application pending·0 cites
- 1671US11939380B2Combination therapies targeting PD-1, TIM-3, and LAG-3SYMPHOGEN AS·Filed 2018·Granted Mar 26, 2024·1 cites·16 claims
- 1767US2022380470A1Combination therapies targeting pd-1, tim-3, and lag-3SYMPHOGEN AS·Filed 2022·Application pending·0 cites
- 1861US12252539B2Anti-FLT3 antibodies and compositionsSERVIER LAB·Filed 2021·Granted Mar 18, 2025·0 cites·14 claims
- 1957US2018344846A1Humanized pan-her antibody compositionsSYMPHOGEN AS·Filed 2018·Application pending·0 cites
- 2055US12030942B2Anti-PD-1 antibodies and compositionsSERVIER LAB·Filed 2021·Granted Jul 9, 2024·0 cites·18 claims
- 2153US2025179195A1Anti-flt3 antibodies and compositionsSERVIER LAB·Filed 2025·Application pending·0 cites
- 2251US2011224094A1Method for identifying and selecting drug candidates for combinatorial drug productsSYMPHOGEN AS·Filed 2009·Application pending·0 cites
- 2350US2016089435A1Pan-her antibody compositionSYMPHOGEN AS·Filed 2015·Application pending·0 cites
- 2448US2021214454A1Anti-cd40 antibodies and compositionsSYMPHOGEN AS·Filed 2021·Application pending·0 cites
- 2531US10450376B2Anti-MET antibodies and compositionsSYMPHOGEN AS·Filed 2015·Granted Oct 22, 2019·0 cites·23 claims
Join the waitlist — get patent alerts
Get an alert when Mikkel Wandahl Pedersen files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →